An international, phase 3 clinical trial led by investigators at Mass General Brigham could improve the treatment of a rare disease that can cause debilitating symptoms.

The weight-loss jab Wegovy made its debut on June 4 2021 . It was the first new weight-loss drug to be approved by the US ...

This week, I have a confession to make: in the two decades that I have been a science journalist, I have contributed to some ...

Enlivex (ENLV) has released an update. Enlivex Therapeutics has commenced the next phase of its Allocetra trial, enrolling and dosing the first ...

A recent study found semaglutide – the drug known as Ozempic – can improve knee pain in people with obesity and ...

Organogenesis (ORGO) announced the favorable outcome of the interim analysis of its second Phase 3 randomized control trial of ReNu, a ...

Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and ...

A new study shows that Ozempic may help ease arthritis knee pain in people with obesity. Here's what to know about the study and whether semaglutide can truly help reduce knee pain, according to ...

Recent clinical studies have revealed groundbreaking developments in treating knee osteoarthritis through metabolic ...

Once-weekly semaglutide shows significant reduction in knee osteoarthritis pain and body weight in adults with obesity, a ...

Osteoarthritis of the knee is a common and often painful condition affecting millions worldwide, especially older adults. As ...